MYBL2 and lung adenocarcinoma: As shown in Figure 1A, high expression of B-Myb was strongly associated with poor overall survival of lung cancer patients in the Nagoya University lung adenocarcinoma (ADC) cohort and Michigan University lung squamous cell carcinoma (SQCC) cohort (p < 0.05).